Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Balance Sheet - Advanced Enzyme Technologies

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 15, 16:00
281.60
-0.2 (-0.07%)
VOLUME 13,810
LIVE
NSE
Dec 15, 15:54
281.90
0.1 (0.04%)
VOLUME 83,623
Download Annual Report PDF Format 2016

Balance Sheet of Advanced Enzyme Technologies

------------------- in Rs. Cr. -------------------
Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
12 mths 12 mths 12 mths 12 mths 12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital 22.33 21.77 21.77 21.77 21.77
Total Share Capital 22.33 21.77 21.77 21.77 21.77
Reserves and Surplus 232.78 153.08 134.40 116.15 107.47
Total Reserves and Surplus 232.78 153.08 134.40 116.15 107.47
Total Shareholders Funds 255.11 174.85 156.17 137.91 129.23
NON-CURRENT LIABILITIES
Long Term Borrowings 12.14 15.60 5.15 15.13 26.90
Deferred Tax Liabilities [Net] 15.30 15.76 14.77 14.45 13.26
Long Term Provisions 0.70 0.18 0.00 0.00 0.00
Total Non-Current Liabilities 28.14 31.54 19.92 29.57 40.16
CURRENT LIABILITIES
Short Term Borrowings 21.13 29.45 22.38 31.74 23.40
Trade Payables 8.48 9.78 7.53 9.08 17.73
Other Current Liabilities 15.95 13.41 14.70 16.47 15.54
Short Term Provisions 1.66 2.52 1.91 2.92 7.09
Total Current Liabilities 47.22 55.17 46.51 60.21 63.75
Total Capital And Liabilities 330.46 261.55 222.59 227.70 233.15
ASSETS
NON-CURRENT ASSETS
Tangible Assets 99.39 101.23 105.72 109.91 113.67
Intangible Assets 0.14 0.05 0.01 0.01 0.02
Capital Work-In-Progress 1.50 1.84 0.24 0.50 0.05
Intangible Assets Under Development 6.55 6.20 4.95 1.13 0.00
Fixed Assets 107.57 109.32 110.92 111.56 113.73
Non-Current Investments 103.39 53.08 27.32 28.02 27.96
Long Term Loans And Advances 16.89 17.82 15.98 16.24 13.61
Other Non-Current Assets 0.14 0.13 0.04 0.11 0.10
Total Non-Current Assets 227.98 180.34 154.26 155.93 155.41
CURRENT ASSETS
Inventories 51.06 47.40 39.38 36.69 35.63
Trade Receivables 31.42 22.78 0.95 28.44 33.53
Cash And Cash Equivalents 0.61 1.54 24.42 1.84 1.92
Short Term Loans And Advances 14.55 2.84 2.86 4.15 6.06
OtherCurrentAssets 4.85 6.65 0.72 0.66 0.59
Total Current Assets 102.48 81.20 68.33 71.77 77.74
Total Assets 330.46 261.55 222.59 227.70 233.15
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities 17.96 19.84 16.63 23.41 10.25
CIF VALUE OF IMPORTS
Raw Materials 18.12 22.94 18.65 10.78 20.62
Stores, Spares And Loose Tools 0.92 1.78 0.70 2.65 2.63
Capital Goods 0.51 1.16 0.24 1.39 0.57
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency 2.39 2.13 3.96 5.52 5.27
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency - 0.53 0.53 1.58 1.02
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods 61.84 45.95 44.60 56.38 58.06
Other Earnings 0.88 0.16 - 0.07 0.97
BONUS DETAILS
Bonus Equity Share Capital - - - - -
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value - - - - -
Non-Current Investments Unquoted Book Value 103.38 53.08 27.32 28.02 27.96
CURRENT INVESTMENTS
Current Investments Quoted Market Value - - - - -
Current Investments Unquoted Book Value - - - - -
Source : Dion Global Solutions Limited

Results of Advanced Enzyme

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for advancedenzymetechnologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.